Objective: Finding out etiology, clinical course, immediate outcome, and association of maternal and neonatal factors that predispose to neonatal thrombocytopenia. Design: Prospective observational study.
Introduction
Neonatal thrombocytopenia is one of the common hematological problems encountered in a neonatal intensive care unit. Platelets appear in fetal circulation as early as 5 weeks of gestation. It reaches an adult value of 150 000 to 450 000/ µL by the second trimester and remains constant throughout life. [1] [2] [3] [4] Therefore, irrespective of the gestational age, the platelet count should be above 150 000/µL and anything less than that should be considered as thrombocytopenia. Depending on platelet count, thrombocytopenia can be classified into mild (platelet count: 100 000-150 000/µL.), moderate (platelet count: 50 000-99 000/µL), severe (platelet count: <50 000/ µL), and very severe (platelet count: <30 000/µL). [15] [16] [17] Thrombocytopenia is present in 1% to 5% of newborns at birth. Severe thrombocytopenia occurs in 0.1% to 0.5%. 1, 2 Thrombocytopenia presenting within the first 72 hours of life is usually secondary to placental insufficiency and caused by reduced platelet production. Fortunately, most such episodes of thrombocytopenia are mild or moderate and can be resolved spontaneously. Thrombocytopenia presenting after 72 hours of life is usually secondary to sepsis or necrotizing enterocolitis and is usually more severe and prolonged.
Thrombocytopenia develops in 22% to 35% of all newborns admitted to neonatal intensive care units (NICUs) and in up to 50% of those admitted to NICUs who require intensive care. About 20% of thrombocytopenic episodes are severe and are at an increased risk of hemorrhage.
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Methods
After a written consent from caretakers, detailed maternal, obstetric, and neonatal history was taken and complete physical examination was done. Investigations for sepsis, bleeding abnormality including neurosonogram were performed as per the requirement. These were managed as per the institutional guideline.
Results
A total of 1255 neonates were admitted during the study period of which thrombocytopenia was found in 413 neonates. Those with the platelet count below 150 × 10 9 /L and those not confirmed by the manual methods (the Neubauer chamber) were excluded. A total of 361 neonates were included in our NICU setting, with the prevalence of thrombocytopenia being 29%. Among 361 neonates, 150 were included in the study after getting the consent from their caretakers. They were divided into 4 groups depending on their lowest platelet count during the stay: 5 (3%) mild, 11 (7%) moderate, 60 (39%) severe, and 74 (51%) with very severe thrombocytopenia ( Figure 1 ). Thrombocytopenia was found to be more common in preterms and intrauterine growth restriction (SGA) babies. Prematurity was significantly found to be associated with thrombocytopenia (P < .05) ( Table 1) . As shown in Table 2 , the most common symptom other than bleeding was not feeding well and lethargy. However, these symptoms are very nonspecific and can be associated with any sick neonates. The most common sign other than bleeding was shock/hypotension. Other common signs were respiratory distress, seizure, bleeding, Birth Asphyxia, apnea, and abdominal distension. (2) 10 Immune-based thrombocytopenia
More than one etiology was present in most of the diagnoses.
The most common etiological diagnosis in all the admitted cases was sepsis (67%) followed by prematurity (52%) and perinatal asphyxia (21%) ( Table 3 ). More than one diagnosis was present in the cases admitted with thrombocytopenia. Disseminated intravascular coagulation, necrotizing enterocolitis, and meconium aspiration syndrome were also some of the important causes identified. Abbreviations: ITP, immune thrombocytopenic purpura; SLE, systemic lupus erythematous; PIH, pregnancy-induced hypertension; PROM, premature rupture of membrane.
Maternal PIH was the most common predisposing risk factor in the mother followed by the premature rupture of the membrane and maternal drug intake (Table 4 ). In our NICU scenario, severe and very severe thrombocytopenia account for around 90% of the admitted cases as shown in Table 5 . Major hemorrhage was defined as hemorrhage (eg, pulmonary haemorrhage) requiring prompt, sustained nursing intervention (eg, repeated endotracheal tube suctioning), or medical intervention (eg, red blood cell transfusion within 24 hours). 8 Minor hemorrhage was defined as one or more than one of the following: blood staining of oral, nasogastric, or endotracheal secretions, or blood in stool; hematuria, petechial rash, or oozing from puncture sites. 8 In this study, out of 150 neonates, 65 neonates were affected with bleeding manifestations. Most of the major or minor bleeding occurred in very severe thrombocytopenia (Table 6 ). In particular, the prognosis was worse in cases that had mucosal hemorrhage, without a relation with the degree of thrombocytopenia.
Among the 60 neonates where platelet transfusion was needed, 38% needed at least 2 units and 33% needed 3 units of platelets. Exchange transfusion was needed in only 8 cases. It was seen that the average duration of stay of the neonates admitted with thrombocytopenia was 13.4 days (±0.7 days). It was almost similar among the groups presenting with very severe and severe thrombocytopenia ( Table 7 ). The duration of hospital stay depends on the platelet count except those who died (Figure 2 ). The mean platelet count at admission was significantly different among the cases as per the final outcome (satisfactory or unsatisfactory and death group), P = .004 (1-way analysis of variance). In those neonates (42%) with death, the mean platelet count at admission was 18660 ± 1324/cumm. The unsatisfactory outcome may or may not be because of thrombocytopenia alone. In this study, 9% developed intracranial hemorrhage mostly seen in the very severe thrombocytopenia group (Table 8) .
Discussion
Thrombocytopenia is one of the most common hematological abnormalities seen in the NICU but may be missed if not specifically looked for. Clinically, thrombocytopenic neonates may vary from asymptomatic to mild oozing from the venipuncture site to severe single organ hemorrhage (pulmonary, gastrointestinal, and intraventricular) to disseminated intravascular coagulation. 9 Fetomaternal and neonatal conditions result in neonatal thrombocytopenia. 10 Maternal PIH was significantly associated with severe neonatal thrombocytopenia. Burrows et al. 11 found maternal PIH to be associated with mild to moderate thrombocytopenia rather than severe thrombocytopenia. The association of severe thrombocytopenia with maternal PIH can be explained by the frequent exposure of these neonates to intrauterine hypoxia and ineffective megakaryopoiesis that leads to a precipitous fall in platelet count causing severe thrombocytopenia.
Mechanisms underlying thrombocytopenia in neonates include increased platelet consumption as seen in sepsis, decreased production because of specifically smaller, less mature megakaryocytes, and low thrombopoietin levels. In premature neonates or those with intrauterine growth restriction, these cases of thrombocytopenia resolve spontaneously. 10 The etiological profile of this study showed that neonatal sepsis (67%) was the leading cause of thrombocytopenia followed by prematurity (52%) as in Table 3 . Gupta et al. 12 and Khalessi et al. 13 found sepsis to be the most common cause of neonatal thrombocytopenia with a proportion of 42% and 24.1% respectively. According to Modanloud et al., 14 thrombocytopenia was frequently associated with bacterial sepsis in neonates. Septicemia leads to thrombocytopenia because of both decreased production and increased consumption of platelets, thereby resulting usually in severe thrombocytopenia. 15 Hence, in neonates with neonatal thrombocytopenia, already compromised hematological environment exposure to an infection probably leads to a precipitous fall in the platelet count, resulting in severe thrombocytopenia. Interventions meant for treating sepsis can thus lead to the correction of thrombocytopenia, which is also a preventable cause, and can prevent admissions because of thrombocytopenia.
Newer classification based on the timing of the onset of thrombocytopenia (early vs late) appears more useful and important for planning diagnostic investigations, and the subsequent management of neonatal thrombocytopenia though an overlap between the two patterns is common. In this study, the presence of the late onset of thrombocytopenia (>72 hours) was 57% and the early onset of thrombocytopenia (<72 hours) was 43%. Study done by Sonam et al. 16 demonstrated that 43.4% was the early and 56.5% was the late onset of thrombocytopenia, which showed that the majority of the severity of the thrombocytopenic infants presented only after 72 hours of life and the most common etiology was the late onset of sepsis.
Mechanical ventilation can lead to thrombocytopenia because of mechanical reasons. Shearing effect on the pulmonary vasculature increases platelet consumption. 17 A slightly larger sample size could have given a clear-cut direction regarding the nature of association. Forty-seven percent of the neonates with severe thrombocytopenia were mechanically ventilated one time or the other. The association has been documented by other studies done in this regard. 17 Other factors such as hypoxia, hyperbilirubinemia, low Apgar's score, exchange transfusion, polycythemia, and respiratory distress syndrome were not significantly associated with thrombocytopenia.
Perinatal asphyxia is reported to be widely associated with neonatal thrombocytopenia. In the present study, there was significant association between perinatal asphyxia and severe thrombocytopenia (P < .05). Nursen et al. 18 demonstrated a relation between the severity of thrombocytopenia and the staging of hypoxic-ischemic encephalopathy. 15 In another study, Sharma and Thapar 19 demonstrated that perinatal asphyxia was significantly associated with thrombocytopenia.
Most of the major or minor bleeding occurred in very severe thrombocytopenia. In particular, the prognosis was worse in cases with mucosal hemorrhage, without a relation with the degree of thrombocytopenia.
The most common symptom other than bleeding was not feeding well and lethargy. But this symptom is nonspecific that can be associated with any sick neonates. The most common sign other than bleeding was shock. This association might be either because of shock in sick neonates, especially septicemic neonates, or because of excessive blood loss. Hence, this is not of much clinical significance. Other common signs are respiratory distress, seizure, bleeding, infants did not cry immediately after birth, apnea, and abdominal distension ( Table 2) .
In the present study, severe thrombocytopenia was found in 50% of neonates and very severe was found in 39% of them. Sonam et al. 16 had shown severe thrombocytopenia to be found in 65.6% of infants in their study. The proportion of very severe thrombocytopenia and severe is higher in this study, whereas other studies showed the predominance of mild thrombocytopenia. This reflects the severity because of a higher contribution of prematurity and septicemia in admission cases.
Von Lindern et al. 20 found that 12% of babies with neonatal thrombocytopenia developed IVH. In another study done by Sonam et al., 16 IVH developed in 5% of babies with neonatal thrombocytopenia. In this study, IVH developed in 8.79% of babies with neonatal thrombocytopenia.
Gupta et al. 12 reported overall mortality in 33% babies with thrombocytopenia. In this study, the mortality of 42% babies with thrombocytopenia was observed. The mortality rate was very high with 30% in very severe thrombocytopenic neonates, whereas it was 9% in the severe thrombocytopenic group of neonates. The association might be because of a higher degree of severity of the underlying illness or the increased susceptibility of neonates to complications in the thrombocytopenic group. Low levels of platelet counts among the admitted neonates were found to be associated with the outcome. Death as an immediate outcome was seen more among neonates admitted with poor platelet counts.
Conclusions
Neonatal thrombocytopenia is a common clinical problem and is a prognostic marker of many disease conditions in neonates. The leading causes of neonatal thrombocytopenia include prematurity, sepsis, respiratory distress syndrome, birth asphyxia, meconium aspiration syndrome, and hyperbilirubinemia, among which sepsis and prematurity contribute to a significant number of severe thrombocytopenia.
The predisposing factors associated with neonatal thrombocytopenia were maternal PIH, maternal drug intake, septicemia, necrotizing enterocolitis, and perinatal asphyxia. As septicemia is the most common cause, death because of severe thrombocytopenia can be prevented with the reduction of the incidence of sepsis in the newborn. Prematurity is the second most common cause but self-limiting if a proper care is taken. Birth asphyxia, which is the third common cause of severe thrombocytopenia, is partly or to a great extent preventable. The mortality rate is very high among very severe thrombocytopenic infants. Low platelet count was found to be an independent risk factor for poor outcome in NICU admitted neonates.
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